News & insights

Access the latest CEPA developments, our case studies and publications

Sectors

Read about our portfolio of sectors and the type of work we conduct in each

About

Find out more about what we do in economic consulting and our company history

Careers

Learn more about working at CEPA, our latest vacancies and how you can contribute to our work

News & insights

Date: October 2014 | Client: Medicines Patent Pool (MPP) | Sector: Global health | Market dynamics, supply & access | Expertise: Health economics & evaluation

Review of Unitaid’s Medicines Patent Pool (MPP)

The Medicines Patent Pool (MPP) is an independent non-profit Swiss Foundation established in July 2010 with the objective of providing patients in low and middle-income countries with increased access to quality, safe, efficacious, appropriate and affordable health products, through a voluntary patent pool mechanism. CEPA undertook a review to closely assess the strategic direction, positioning and operations of the MPP; draw lessons from the MPP’s experience to date; and provide recommendations for improved performance.

The evaluation conclusions and recommendations were presented to the Unitaid Board in June 2014 to inform their decision on future funding to the MPP. CEPA used a mixed methods approach, including a desk-based review of relevant documentation and structured interviews with a range of stakeholders (including Unitaid, MPP, pharmaceutical industry players, civil society organisations) to draw any relevant lessons for the MPP.

To find out more, please contact our experts listed below.

Clare Strachan
Principal (acting) United Kingdom